Artwork

Content provided by Colossus, Colossus | Investing, and Business Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colossus, Colossus | Investing, and Business Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Novocure: Using Physics to Fight Cancer - [Business Breakdowns, EP. 37]

57:33
 
Share
 

Manage episode 308406061 series 2906026
Content provided by Colossus, Colossus | Investing, and Business Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colossus, Colossus | Investing, and Business Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Today, we’re breaking down Novocure, a global oncology company that has pioneered a new approach to cancer treatment. For over 100 years, the tools used to fight cancer have largely remained unchanged, but there are promising signs of a renaissance and Novocure is at the vanguard of that charge.

To explain the state of cancer research and how the business has developed over the past twenty years, I’m joined by Bill Doyle – Novocure’s Executive Chairman. Please enjoy this breakdown of Novocure.

For the full show notes, transcript, and links to the best content to learn more, check out the episode page here.

-----

Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.

Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.

Follow us on Twitter: @JoinColossus | @patrick_oshag | @jspujji | @zbfuss

Show Notes

[00:03:05] - [First question] - The current state of cancer treatment today writ large

[00:05:43] - What cancer is and how it becomes life threatening

[00:06:38] - Why uncontrolled cell growth is so bad

[00:07:27] - The main three ways we currently treat cancer

[00:11:29] - Whether or not there are targeted ways we can treat cancer like mRNA

[00:14:08] - How we’ve historically detected cancer and what future detection could look like

[00:17:12] - Death rates of cancer in the US annually and the business side as it stands today

[00:18:20] - Key players in the cancer treatment space that serve patients

[00:19:13] - The pioneering technology that Novocure created to treat cancer

[00:22:38] - The mechanism that allows their tech to target the right cells

[00:25:35] - Overview of the actual procedure that takes place with their therapy

[00:28:36] - The impact and results of their new treatment method

[00:33:37] - A future where we can take this in a prophylactic and preventive sense

[00:34:44] - Why this approach to cancer treatment isn’t more widely known and accepted

[00:38:09] - Financials of Novocure and the opportunities it presents for their business

[00:43:10] - How they spend their R&D dollars and horizontal and vertical growth

[00:48:01] - Unique ways how they spend their revenue to scale their business

[00:51:05] - Biggest criticisms of the size and scope of Novocure

[00:52:18] - Broader business lessons learned while building a cancer treatment company

[00:55:23] - The future of healthcare more generally and what has him most excited

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

170 episodes

Artwork
iconShare
 
Manage episode 308406061 series 2906026
Content provided by Colossus, Colossus | Investing, and Business Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colossus, Colossus | Investing, and Business Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Today, we’re breaking down Novocure, a global oncology company that has pioneered a new approach to cancer treatment. For over 100 years, the tools used to fight cancer have largely remained unchanged, but there are promising signs of a renaissance and Novocure is at the vanguard of that charge.

To explain the state of cancer research and how the business has developed over the past twenty years, I’m joined by Bill Doyle – Novocure’s Executive Chairman. Please enjoy this breakdown of Novocure.

For the full show notes, transcript, and links to the best content to learn more, check out the episode page here.

-----

Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.

Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.

Follow us on Twitter: @JoinColossus | @patrick_oshag | @jspujji | @zbfuss

Show Notes

[00:03:05] - [First question] - The current state of cancer treatment today writ large

[00:05:43] - What cancer is and how it becomes life threatening

[00:06:38] - Why uncontrolled cell growth is so bad

[00:07:27] - The main three ways we currently treat cancer

[00:11:29] - Whether or not there are targeted ways we can treat cancer like mRNA

[00:14:08] - How we’ve historically detected cancer and what future detection could look like

[00:17:12] - Death rates of cancer in the US annually and the business side as it stands today

[00:18:20] - Key players in the cancer treatment space that serve patients

[00:19:13] - The pioneering technology that Novocure created to treat cancer

[00:22:38] - The mechanism that allows their tech to target the right cells

[00:25:35] - Overview of the actual procedure that takes place with their therapy

[00:28:36] - The impact and results of their new treatment method

[00:33:37] - A future where we can take this in a prophylactic and preventive sense

[00:34:44] - Why this approach to cancer treatment isn’t more widely known and accepted

[00:38:09] - Financials of Novocure and the opportunities it presents for their business

[00:43:10] - How they spend their R&D dollars and horizontal and vertical growth

[00:48:01] - Unique ways how they spend their revenue to scale their business

[00:51:05] - Biggest criticisms of the size and scope of Novocure

[00:52:18] - Broader business lessons learned while building a cancer treatment company

[00:55:23] - The future of healthcare more generally and what has him most excited

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

170 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide